These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


460 related items for PubMed ID: 18345974

  • 21. Recent advances in neurobiology of Tuberous Sclerosis Complex.
    Napolioni V, Moavero R, Curatolo P.
    Brain Dev; 2009 Feb; 31(2):104-13. PubMed ID: 19028034
    [Abstract] [Full Text] [Related]

  • 22. Seizure remission and antiepileptic drug discontinuation in children with tuberous sclerosis complex.
    Sparagana SP, Delgado MR, Batchelor LL, Roach ES.
    Arch Neurol; 2003 Sep; 60(9):1286-9. PubMed ID: 12975296
    [Abstract] [Full Text] [Related]

  • 23. [Autism, epilepsy and tuberous sclerosis complex: a functional model linked to mTOR pathway].
    García-Peñas JJ, Carreras-Sááez I.
    Rev Neurol; 2013 Feb 22; 56 Suppl 1():S153-61. PubMed ID: 23446718
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Epilepsy in TSC: certain etiology does not mean certain prognosis.
    Vignoli A, La Briola F, Turner K, Scornavacca G, Chiesa V, Zambrelli E, Piazzini A, Savini MN, Alfano RM, Canevini MP.
    Epilepsia; 2013 Dec 22; 54(12):2134-42. PubMed ID: 24304436
    [Abstract] [Full Text] [Related]

  • 26. Cardiac rhabdomyomas in tuberous sclerosis complex show apoptosis regulation and mTOR pathway abnormalities.
    Kotulska K, Larysz-Brysz M, Grajkowska W, Jóźwiak J, Włodarski P, Sahin M, Lewin-Kowalik J, Domańska-Pakieła D, Jóźwiak S.
    Pediatr Dev Pathol; 2009 Dec 22; 12(2):89-95. PubMed ID: 17990907
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Spectrum of epilepsy in tuberous sclerosis.
    Anisya-Vasanth AV, Satishchandra P, Nagaraja D, Swamy HS, Jayakumar PN.
    Neurol India; 2004 Jun 22; 52(2):210-2. PubMed ID: 15269473
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Enhanced episodic-like memory and kindling epilepsy in a rat model of tuberous sclerosis.
    Waltereit R, Welzl H, Dichgans J, Lipp HP, Schmidt WJ, Weller M.
    J Neurochem; 2006 Jan 22; 96(2):407-13. PubMed ID: 16300636
    [Abstract] [Full Text] [Related]

  • 35. Mechanistic target of rapamycin (mTOR) in tuberous sclerosis complex-associated epilepsy.
    Curatolo P.
    Pediatr Neurol; 2015 Mar 22; 52(3):281-9. PubMed ID: 25591831
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Mutational analysis of TSC1 and TSC2 in Korean patients with tuberous sclerosis complex.
    Choi JE, Chae JH, Hwang YS, Kim KJ.
    Brain Dev; 2006 Aug 22; 28(7):440-6. PubMed ID: 16554133
    [Abstract] [Full Text] [Related]

  • 39. Vigabatrin for partial-onset seizure treatment in patients with tuberous sclerosis complex.
    Friedman D, Bogner M, Parker-Menzer K, Devinsky O.
    Epilepsy Behav; 2013 Apr 22; 27(1):118-20. PubMed ID: 23399947
    [Abstract] [Full Text] [Related]

  • 40. The tuberous sclerosis genes, TSC1 and TSC2, trigger different gene expression responses.
    Rosner M, Freilinger A, Lubec G, Hengstschläger M.
    Int J Oncol; 2005 Nov 22; 27(5):1411-24. PubMed ID: 16211238
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 23.